News & Events category:
Saint Mary's Hospital

Babies at MFT have been part of groundbreaking research which found that a single dose of a treatment for a respiratory infection in infants can help cut hospital admissions by more than 80 per cent.

New research has shown that empowering women to self-manage a common treatment for pelvic organ prolapse leads to fewer complications and could save the NHS more than £560 per patient.

More than 1,100 pregnant women on the North Manchester site of Saint Mary’s Managed Clinical Service, have taken part in a rapid beside test to protect newborns from life-threatening illnesses.

Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.

The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.

ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.

A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.

An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.